Phase 4 Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For the Normal-Weight Diabetes group:
- People aged 30 to 70 years old who have been diagnosed with Type 2 Diabetes (or whose blood sugar results at screening confirm it).
- People whose HbA1c (a measure of average blood sugar over time) is between 5.7% and 8%, and whose diabetes treatment plan — whether medication or lifestyle changes — has stayed the same for at least 3 months.
- People with a body mass index (BMI) between 19 and 24.9 kg/m² (considered a "normal" weight range).
- People taking diabetes medications are generally welcome, except those currently using insulin or pioglitazone — other medications, including certain injectable diabetes drugs (GLP-1 receptor agonists), may be allowed if the dose has been unchanged for at least 3 months.
- People whose body weight has changed by no more than 2 kg over the past 3 months.
For the Normal-Weight Control group (no diabetes):
- People aged 30 to 70 years old with no diagnosis of diabetes and blood sugar results within the normal range.
- People with a BMI between 19 and 24.9 kg/m² who have never taken blood sugar-lowering medication.
- People whose body weight has changed by no more than 2 kg over the past 3 months.
Who may not be able to join:
- People who are pregnant, planning to become pregnant, or currently breastfeeding.
- People who have previously taken a diabetes medication called pioglitazone.
- People whose body weight has changed by more than 2 kg in the last 3 months.
- People with significant liver problems (based on a specific liver enzyme test result) or significant kidney problems (based on a specific kidney function test result).
- People with a history of heart failure or a condition involving excess fluid build-up in the body.
- People with high blood pressure that is not well controlled (above 160/90 mmHg).
- People who have been diagnosed with cancer in the past 3 years (skin cancer may be an exception — confirm with trial site).
- People with ongoing chronic inflammatory diseases.
- People currently taking weight-loss medications.
- People who have had weight-loss (bariatric) surgery or liposuction in the past.
- People currently using insulin.
- People with an active psychiatric condition or an eating disorder.
- People with a history of substance abuse.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 408-896-0134
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Insulin resistance in normal weight women with diabetes compared to those with no diabetes; Adipocyte function in women with normal weight diabetes as compared with those without diabetes; Fat storage in women with normal weight diabetes compared to those without diabetes
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.